AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32766862 — intervention group
Group type: EXPERIMENTAL
Intervention: Other referral approaches (e.g., presentations, word of mouth)
Number of subjects: 313
Study 32766862 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall referral pathways
Number of subjects: 313
Study 33559816 — intervention group
Group type: EXPERIMENTAL
Intervention: Solution-oriented counseling
Number of subjects: 56
Study 33559816 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 56
Study 32389457 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-injected subcutaneous depot medroxyprogesterone acetate (DMPA-SC)
Number of subjects: 731
Study 32389457 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider-administered subcutaneous depot medroxyprogesterone acetate (DMPA-SC)
Number of subjects: 731
Study 32389457 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-injected and provider-administered subcutaneous depot medroxyprogesterone acetate (DMPA-SC)
Number of subjects: 731
Study 36178914 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional foods index (measured as weekly servings of traditional food consumption divided by total foods reported)
Number of subjects: 291
Study 36178914 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional foods index during summer
Number of subjects: 291
Study 36178914 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional foods index during winter
Number of subjects: 291
Study 36178914 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional foods index by gender (women)
Number of subjects: 291
Study 36178914 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional foods index by gender (men)
Number of subjects: 291
Study 36178914 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional foods index by community size (smaller communities)
Number of subjects: 291
Study 36178914 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional foods index by community size (larger community of Nome)
Number of subjects: 291
Study 36178914 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with age
Number of subjects: 291
Study 36178914 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with community connectedness
Number of subjects: 291
Study 36178914 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with community standing
Number of subjects: 291
Study 36178914 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with traditional language comprehension
Number of subjects: 291
Study 36178914 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate regression model
Number of subjects: 291
Study 34293213 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher genetic risk score (GRS) for IGF‐1
Number of subjects: 2011
Study 34293213 — intervention group
Group type: EXPERIMENTAL
Intervention: Summary statistics‐based MR method, inverse‐variance weighting (IVW)
Number of subjects: 2011
Study 34293213 — intervention group
Group type: COMPARATOR
Intervention: High GRS group (compared to low GRS group)
Number of subjects: 2011
Study 33318391 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily salt intake estimated using the INTERSALT equation from morning spot urine samples.
Number of subjects: 426
Study 33318391 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist circumference measurement.
Number of subjects: 426
Study 35079838 — intervention group
Group type: EXPERIMENTAL
Intervention: PRESIONA (therapeutic exercise and blood flow restriction program)
Number of subjects: 80
Study 35079838 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 80
Study 33338232 — intervention group
Group type: EXPERIMENTAL
Intervention: Sofosbuvir/daclatasvir plus hydroxychloroquine
Number of subjects: 55
Study 33338232 — intervention group
Group type: COMPARATOR
Intervention: Hydroxychloroquine alone
Number of subjects: 55
Study 34553480 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised, targeted step count intervention and usual care
Number of subjects: 96
Study 34553480 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 96
Study 32686116 — intervention group
Group type: EXPERIMENTAL
Intervention: reminder + FIT
Number of subjects: 35000
Study 32686116 — intervention group
Group type: COMPARATOR
Intervention: reminder-only
Number of subjects: 35000
Study 33892170 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group received glaucoma education, personalized disease management suggestions, and a reminder aid
Number of subjects: 0
Study 33892170 — intervention group
Group type: COMPARATOR
Intervention: Control group received education regarding general eye health
Number of subjects: 0
Study 33892170 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 0
Study 33231866 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine (1000 mg/m2 on days 1 and 8) + Pazopanib (800 mg daily)
Number of subjects: 90
Study 33231866 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine (900 mg/m2 on days 1 and 8) + Docetaxel (100 mg/m2 on day 8)
Number of subjects: 90
Study 33231866 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine + Docetaxel
Number of subjects: 90
Study 33231866 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine + Pazopanib
Number of subjects: 90
Study 34789450 — intervention group
Group type: EXPERIMENTAL
Intervention: CAL-assisted PDT (calcipotriol applied daily for 15 days beforehand)
Number of subjects: 20
Study 34789450 — intervention group
Group type: COMPARATOR
Intervention: Conventional PDT
Number of subjects: 20
Study 34789450 — intervention group
Group type: EXPERIMENTAL
Intervention: CAL-assisted PDT
Number of subjects: 20
Study 33164226 — intervention group
Group type: EXPERIMENTAL
Intervention: Renewed consistent practice for pressure ulcer prevention based on international guidelines.
Number of subjects: 141
Study 36031694 — intervention group
Group type: EXPERIMENTAL
Intervention: Hippotherapy simulation exercise
Number of subjects: 40
Study 36031694 — intervention group
Group type: COMPARATOR
Intervention: Conventional home exercises
Number of subjects: 40
Study 33432646 — intervention group
Group type: EXPERIMENTAL
Intervention: KgDRL (knowledge-guided deep reinforcement learning)
Number of subjects: 74
Study 33432646 — intervention group
Group type: COMPARATOR
Intervention: Standard DRL (deep reinforcement learning)
Number of subjects: 74
Study 33432646 — intervention group
Group type: COMPARATOR
Intervention: Rule-based treatment planning
Number of subjects: 74
Study 33357218 — intervention group
Group type: EXPERIMENTAL
Intervention: Transverse uterine incision
Number of subjects: 52
Study 33357218 — intervention group
Group type: COMPARATOR
Intervention: Longitudinal uterine incision
Number of subjects: 52
Study 34653732 — intervention group
Group type: EXPERIMENTAL
Intervention: Nanocurcumin (80 mg capsule daily for 8 weeks)
Number of subjects: 36
Study 32579483 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined (dexmedetomidine + epidural blockade)
Number of subjects: 96
Study 32579483 — intervention group
Group type: COMPARATOR
Intervention: Control (0.9% saline)
Number of subjects: 96
Study 32883337 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength-based case management (SBCM-ED) with a maximum of six case management sessions within 90 days of enrollment
Number of subjects: 300
Study 32883337 — intervention group
Group type: COMPARATOR
Intervention: Screening, assessment, and referral alone (SAR)
Number of subjects: 300
Study 35302529 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor imagery + action observation therapy
Number of subjects: 30
Study 35302529 — intervention group
Group type: COMPARATOR
Intervention: Cognitive training
Number of subjects: 30
Study 35302529 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed therapy (cognitive training + motor imagery + action observation therapy)
Number of subjects: 30
Study 36262507 — intervention group
Group type: EXPERIMENTAL
Intervention: 200mg of simethicone (Group A)
Number of subjects: 99
Study 36262507 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Group B)
Number of subjects: 99
Study 34374847 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis-derived communication (HC) administered by trained nurses during outpatient chemotherapy.
Number of subjects: 49
Study 34374847 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 49
Study 36197257 — intervention group
Group type: EXPERIMENTAL
Intervention: Printed education materials plus personal education
Number of subjects: 61
Study 36197257 — intervention group
Group type: COMPARATOR
Intervention: Printed education materials only (Control)
Number of subjects: 61
Study 33199422 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium selenate (15 mg three times a day)
Number of subjects: 120
Study 33199422 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 35697435 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBGT)
Number of subjects: 75
Study 35697435 — intervention group
Group type: COMPARATOR
Intervention: Waitlist
Number of subjects: 75
Study 34393186 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric Bypass (GB)
Number of subjects: 60
Study 34393186 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleeve Gastrectomy (SG)
Number of subjects: 60
Study 34393186 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric Bypass (GB) - Noncomplete Remitters
Number of subjects: 60
Study 34393186 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleeve Gastrectomy (SG) - Nonremitters
Number of subjects: 60
Study 35589674 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined paracetamol-dexamethasone
Number of subjects: 100
Study 35589674 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol
Number of subjects: 100
Study 34226220 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery (CRS)
Number of subjects: 0
Study 34375855 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise therapy with booster sessions
Number of subjects: 75
Study 34375855 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise therapy plus manual therapy
Number of subjects: 75
Study 34375855 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise therapy plus manual therapy with booster sessions
Number of subjects: 75
Study 34375855 — intervention group
Group type: COMPARATOR
Intervention: Exercise therapy (control group)
Number of subjects: 75
Study 35338648 — intervention group
Group type: EXPERIMENTAL
Intervention: Restricted IV fluid therapy
Number of subjects: 1554
Study 35338648 — intervention group
Group type: COMPARATOR
Intervention: Standard IV fluid therapy
Number of subjects: 1554
Study 33200899 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic simple prostatectomy (LSP)
Number of subjects: 110
Study 33200899 — intervention group
Group type: COMPARATOR
Intervention: Robot-assisted simple prostatectomy (RASP)
Number of subjects: 110
Study 33200899 — intervention group
Group type: COMPARATOR
Intervention: Holmium laser enucleation of prostate (HoLEP)
Number of subjects: 110
Study 32599641 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity training program
Number of subjects: 23
Study 32599641 — intervention group
Group type: COMPARATOR
Intervention: Moderate-intensity training program
Number of subjects: 23
Study 35918278 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised surgical procedure
Number of subjects: 20
Study 35918278 — intervention group
Group type: COMPARATOR
Intervention: Unsupervised surgical procedure
Number of subjects: 20
Study 33538030 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anesthesia (preservative free morphine sulfate, 0.09 mg/kg; 1% ropivacaine, 0.2 mg/kg; total volume delivered, 1 mL/4.5 kg of body weight to a maximum of 10 mL; n = 9)
Number of subjects: 26
Study 33538030 — intervention group
Group type: COMPARATOR
Intervention: Nonepidural control (n = 13)
Number of subjects: 26
Study 33538030 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anesthesia
Number of subjects: 26
Study 32541328 — intervention group
Group type: EXPERIMENTAL
Intervention: mFOLFOX regimen
Number of subjects: 0
Study 32541328 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 0
Study 32541328 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant therapy
Number of subjects: 0
Study 35230585 — intervention group
Group type: EXPERIMENTAL
Intervention: FEC-100 (6 cycles of 5-FU, epirubicin, and cyclophosphamide)
Number of subjects: 2722
Study 35230585 — intervention group
Group type: COMPARATOR
Intervention: AC (4 cycles of doxorubicin and cyclophosphamide)
Number of subjects: 2722
Study 35230585 — intervention group
Group type: EXPERIMENTAL
Intervention: FEC-100
Number of subjects: 2722
Study 32171875 — intervention group
Group type: COMPARATOR
Intervention: Conventional root canal therapy (Group I)
Number of subjects: 30
Study 32171875 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional root canal therapy combined with antimicrobial PDT (Group II)
Number of subjects: 30
Study 36241464 — intervention group
Group type: EXPERIMENTAL
Intervention: ProTaper Next
Number of subjects: 18
Study 36241464 — intervention group
Group type: EXPERIMENTAL
Intervention: Fanta AF baby
Number of subjects: 18
Study 36241464 — intervention group
Group type: EXPERIMENTAL
Intervention: Kidzo Elephant
Number of subjects: 18
Study 33404083 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive school physical activity and healthy eating program
Number of subjects: 628
Study 33404083 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (no specific intervention mentioned)
Number of subjects: 628
Study 33610421 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine (3 gr/d for 10 weeks)
Number of subjects: 50
Study 33610421 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 32456618 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile SMS counselling intervention
Number of subjects: 384
Study 33930939 — intervention group
Group type: EXPERIMENTAL
Intervention: PMA-zeolite
Number of subjects: 41
Study 33930939 — intervention group
Group type: COMPARATOR
Intervention: Microcrystalline cellulose (control)
Number of subjects: 41
Study 35948699 — intervention group
Group type: EXPERIMENTAL
Intervention: LLLT with nimesulide (N-P group)
Number of subjects: 40
Study 35948699 — intervention group
Group type: COMPARATOR
Intervention: Nimesulide alone
Number of subjects: 40
Study 35948699 — intervention group
Group type: COMPARATOR
Intervention: LLLT alone
Number of subjects: 40
Study 33540223 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based mind-body physical activity intervention with Fitbit (GetActive-Fitbit; n = 41)
Number of subjects: 82
Study 33540223 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based mind-body physical activity intervention without Fitbit (GetActive; n = 41)
Number of subjects: 82
Study 33540223 — intervention group
Group type: COMPARATOR
Intervention: Both interventions (GetActive-Fitbit and GetActive)
Number of subjects: 82
Study 32282100 — intervention group
Group type: EXPERIMENTAL
Intervention: Vyxeos (daunorubicin-cytarabine) liposome injection
Number of subjects: 0
Study 32282100 — intervention group
Group type: COMPARATOR
Intervention: Standard 3+7 daunorubicin and cytarabine
Number of subjects: 0
Study 36294856 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane Block (ESPB) using 20 mL of 0.5% ropivacaine bilaterally
Number of subjects: 59
Study 36294856 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ESPB)
Number of subjects: 59
Study 36294856 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane Block (ESPB)
Number of subjects: 59
Study 33385980 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 1248
Study 33385980 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 1248
Study 33385980 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy (MT) alone
Number of subjects: 1248
Study 35649656 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple calculation and reading aloud
Number of subjects: 0
Study 35649656 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 34384638 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-strand round twisted (RT) retainer
Number of subjects: 133
Study 34384638 — intervention group
Group type: COMPARATOR
Intervention: 8-strand rectangular braided (RB) retainer
Number of subjects: 133
Study 34384638 — intervention group
Group type: EXPERIMENTAL
Intervention: Both RT and RB retainers
Number of subjects: 133
Study 34384638 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodontal parameters (periodontal index, bleeding on probing, plaque index, gingival index, probing depth)
Number of subjects: 133
Study 32160765 — intervention group
Group type: EXPERIMENTAL
Intervention: Left prefrontal transcranial magnetic stimulation (TMS) targeting specific brain circuits for dysphoric symptoms (sadness and anhedonia)
Number of subjects: 198
Study 32160765 — intervention group
Group type: EXPERIMENTAL
Intervention: Left prefrontal transcranial magnetic stimulation (TMS) targeting specific brain circuits for anxiety and somatic symptoms
Number of subjects: 198
Study 32160765 — intervention group
Group type: EXPERIMENTAL
Intervention: Active TMS stimulation
Number of subjects: 198
Study 32160765 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 198
Study 35227659 — intervention group
Group type: EXPERIMENTAL
Intervention: Developed equation using BMI, age, and sex
Number of subjects: 107
Study 35227659 — intervention group
Group type: COMPARATOR
Intervention: Deurenberg equation
Number of subjects: 107
Study 33076952 — intervention group
Group type: EXPERIMENTAL
Intervention: Active‐assistive robotic intervention (ACT)
Number of subjects: 20
Study 33076952 — intervention group
Group type: COMPARATOR
Intervention: Passive robotic intervention (PSV)
Number of subjects: 20
Study 35244061 — intervention group
Group type: EXPERIMENTAL
Intervention: Bojungikgi-tang (BJT) granules administered twice a day for 8 weeks
Number of subjects: 40
Study 35244061 — intervention group
Group type: COMPARATOR
Intervention: Usual care (no BJT granules)
Number of subjects: 40
Study 35244061 — intervention group
Group type: EXPERIMENTAL
Intervention: BJT
Number of subjects: 40
Study 33029527 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound trainee
Number of subjects: 35
Study 33029527 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiology trainee
Number of subjects: 35
Study 33029527 — intervention group
Group type: COMPARATOR
Intervention: Trainees vs. laparoscopy/histology
Number of subjects: 35
Study 35771533 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula/long-term oxygen therapy
Number of subjects: 104
Study 35771533 — intervention group
Group type: COMPARATOR
Intervention: Long-term oxygen therapy
Number of subjects: 104
Study 34253233 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-ALA HCl 15 mg/kg
Number of subjects: 54
Study 34253233 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-ALA HCl 30 mg/kg
Number of subjects: 54
Study 34253233 — intervention group
Group type: COMPARATOR
Intervention: No 5-ALA
Number of subjects: 54
Study 35532732 — intervention group
Group type: EXPERIMENTAL
Intervention: MED-WELL programme (exercise intervention)
Number of subjects: 0
Study 35532732 — intervention group
Group type: COMPARATOR
Intervention: MBSR programme (control)
Number of subjects: 0
Study 33593066 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated workflow for rational construction of plasmids and their conjugative transfer into Corynebacterium glutamicum
Number of subjects: 0
Study 32803636 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea supplements (1 g twice daily; containing 300 mg EGCG)
Number of subjects: 0
Study 32803636 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen monotherapy
Number of subjects: 0
Study 33822033 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone (25-50 mg/day)
Number of subjects: 527
Study 33822033 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 527
Study 32355067 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 1443
Study 32355067 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel (in diabetic patients)
Number of subjects: 1443
Study 34085581 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed-Release and Extended-Release Methylphenidate (DR/ER-MPH)
Number of subjects: 0
Study 34085581 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32650682 — intervention group
Group type: EXPERIMENTAL
Intervention: Cartilage push-through technique
Number of subjects: 93
Study 32650682 — intervention group
Group type: COMPARATOR
Intervention: Underlay fascia graft technique
Number of subjects: 93
Study 34120525 — intervention group
Group type: EXPERIMENTAL
Intervention: Manager-targeted educational intervention (3-hour seminar)
Number of subjects: 915
Study 33831981 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT)
Number of subjects: 26
Study 33831981 — intervention group
Group type: COMPARATOR
Intervention: Control group (no OMT)
Number of subjects: 26
Study 33303428 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual therapy (1 to 3 sessions at intervals of one per week)
Number of subjects: 0
Study 33303428 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid injections (1 mL of Diprostène via ultrasound-guided injection)
Number of subjects: 0
Study 35041046 — intervention group
Group type: EXPERIMENTAL
Intervention: Extruded rice snacks containing 400 mg DHA from cauliflower-encapsulated HiDHA® algal oil
Number of subjects: 27
Study 35041046 — intervention group
Group type: EXPERIMENTAL
Intervention: Soup containing 400 mg DHA from cauliflower-encapsulated HiDHA® algal oil
Number of subjects: 27
Study 35041046 — intervention group
Group type: COMPARATOR
Intervention: Gel capsules containing HiDHA® algal oil
Number of subjects: 27
Study 35838817 — intervention group
Group type: EXPERIMENTAL
Intervention: Baduanjin exercise (BDJ)
Number of subjects: 135
Study 35838817 — intervention group
Group type: EXPERIMENTAL
Intervention: Brisk walking (BWK)
Number of subjects: 135
Study 35838817 — intervention group
Group type: COMPARATOR
Intervention: Usual physical activity (UPA)
Number of subjects: 135
Study 33046619 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexiletine (150 mg 3 times daily)
Number of subjects: 42
Study 33046619 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexiletine
Number of subjects: 42
Study 33046619 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42